Ductal carcinoma in situ of the breast (DCIS) - Treatment modalities;L'approche therapeutique des carcinomes canalaires in situ (CCIS)

Sein

Volumn 13, Issue 2, 2003, Pages 114-125

  Cutuli, B ^a  

^a Polyclinique de Courlancy   (France)

Author keywords

Conservative treatment; Ductal carcinoma in situ (DCIS); Local recurrence; Mastectomy; Radiotherapy

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

AXILLA; BREAST CARCINOMA; BREAST DUCT; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; CARCINOMA IN SITU; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DUCTAL CARCINOMA IN SITU; HUMAN; LYMPH NODE METASTASIS; MAMMOGRAPHY; MASTECTOMY; PROGNOSIS; RADIATION DOSE; RANDOMIZATION; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0038148375     PISSN: 11631961     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (66)

1. SILVERSTEIN MJ. Ductal carcinoma in situ of the breast. Annu Rev Med 2000; 51: 17-32.
2. SCHWARTZ GF, SOLIN LJ, OLIVOTTO IA, et al. Consensus Conference on the treatment of in situ Ductal Carcinoma of the breast, April 22-25,1999. Cancer 2000; 88: 946-954.
3. SILVERSTEIN MJ, LAGIOS MD, MARTINO S, et al. Outcome after invasive local recurrence inpatients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16: 1367-1373.
4. BIJKER N, PETERSE JL, DUCHATEAU L, et al. Risk factor for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organisation for Research and Treatment of Cancer trial 10853. J Clin Oncol 2001; 19: 2263-2271.
5. CUTULI B, COHEN-SOLAL-LE NIR C, DE LA FONTAN B, et al. Ductal Carcinoma in situ of the breast. Results of conservative and radical treatments in 716 patients. Eur J Cancer 2001; 37: 2365-2372.
6. SKINNER KA, SILVERSTEIN MJ. The management of ductal carcinoma in situ of the breast. Ca, Cancer J Clin 2000; 50: 7-33.
7. SILVERSTEIN MJ. The Van Nuys/USC Experience by treatment. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 337-342.
8. TUNON DE LARA C, DE MASCAREL I, MAC GROGAN G, et al. Analysis of 676 ductal carcinoma in situ (DCIS) of the breast from 1971 to 1995: diagnosis and treatment; the experience of one institute. Am J Clin Oncol 2001; 24: 531-536.
9. MORROW M, BRINKMANN E. Surgical overview of the treatment of ductal carcinoma in situ. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 275-286.
10. PETIT JY, VILCOQ JR, CONTESSO G, ZAFRANI B, MOURIESSE H, BARREAU-POUHAER L. Le traitement des cancers intracanalaires. In: Lansac J., Lefloch O., Bougnoux P. eds. Dépistage du cancer du sein et conséquences thérapeutiques. Paris: Masson, 1989, 115-120.
11. GROTTING JC, HENDERSON JL. Mastectomy and immediate reconstruction for extensive DCIS. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 515-522.
12. CIATTO S, GRAZZINI G, IOSSA A, et al. In situ ductal carcinoma of the breast: analysis of clinical presentation and outcome in 156 consecutive cases. Eur J Surg Oncol 1990; 16: 220-224.
13. CUTULI B, COHEN SOLAL LE NIR C, DE LAFONTAN B, et al. Breast conserving therapy for ductal carcinoma in stiu of the breast: the French Cancer centers' experience. Int J Radiat Oncol Biol Phys 2002; 53: 868-879.
14. LAGIOS MD. The Lagios experience. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 303-307.
15. SCHWARTZ GF. Treatment of subclinical ductal carcinoma in situ of the breast by local excision and surveillance: an update personal experience. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 308-321.
16. ARNESSON LG, OLSEN K. Linköping experience. In: Ductal Carcinoma in situ of the breast. Silverstein MJ ed., Baltimore, Williams and Wilkins, 1997, 373-377.
17. CUTULI B, COHEN SOLAL LE NIR C, DE LAFONTAN B, et al. Ductal carcinoma in situ: collected experience of the French regional comprehensive cancer centers. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 400-406.
18. FOURQUET A, ZIGAL-ZAFRANI B, CLOUGH KB. Breast-conserving surgery plus radiation therapy in ductal carcinoma in situ: The Institut Curie Experience. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 367-372.
19. CATALIOTTI L, DISTANTE V, ORZALESI L, et al. The Florence Experience. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 348-353.
20. BONNIER P, BODY G, BESSENAY F, et al. Prognostic factors in ductal carcinoma in situ of the breast: results of a retrospective study of 575 cases. The association for research in oncologic gynaecology. Eur J Obstet Gyne Reprod Biol 1999; 84: 27-35.
21. FOWBLE B, HANLON AL, FEIN DA, et al. Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS). Int J rad Oncol Biol Phys 1997; 38: 949-957.
22. VAN ZEE KJ, LIBERMAN L, SAMLI B, et al. Long-term follow-up of women with ductal carcinoma in situ treated with breast conserving surgery. The effect of age. Cancer 1999; 86: 1757-1767.
23. DENOUX Y, MARNAY J, CROUET H, et al. Evaluation des facteurs pr6dictifs des r6cidives locales, en particulier de l'index de Van Nuys, dans les carcinomes intracanalaires du sein: étude de 166 cas avec traitement conservateur et revue de la littérature. Bull Cancer 2001; 88: 419-425.
24. AMICHETTI M, CAFFO O, RICHETTI A, et al. Ten-year results of treatment of ductal carcinoma in situ (DCIS) of the breast with conservative surgery and radiotherapy. Eur J Cancer 1997; 33: 1559-1165.
25. HARRIS EE, SCHULTZ DJ, PETERS CA, SOLIN LJ. Relationship of family history and outcome after breast conservation therapy in women with ductal carcinoma in situ of the breast. Int J Rad Oncol Biol Phys 2000; 48: 933-942.
26. VICINI FA, LACERNA MD, GOLDSTEIN NS, et al. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. Int J Radiat Oncol Biol Phys 1997; 39: 627-365.
27. AMALRIC R, BRANDONE H, DUBAU A, et al. Résultat du traitement par chirurgie conservatrice et irradiation de 132 carcinomes canalaires in situ non palpable du sein. Cancer Radiother 1998; 2:19-26.
28. SOLIN LJ, FOURQUET A, VICINI F, et al. Mammographically detected Ductal Carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation long-term outcome and prognostic significance of patient age and margin status. Int J Radiot Oncol Biol Phys 2001; 50: 991-1102.
29. SOLIN LJ, KURTZ J, FOURQUET A, et al. Fifteen-year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 754-763.
30. MIRZA NQ, VLASTOS G, MERIC F, et al. Ductal Carcinoma in situ: long-term results of breast conserving therapy. Ann Surg Oncol 2000; 7: 656-664.
31. FISHER B, COSTANTINO J, REDMOND C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581-1586.
32. FISHER B, DIGNAM J, WOLMARK N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441-452.
33. FISHER B, LAND S, MAMOUNAS E, DIGNAM J, FISHER ER, WOLMARK N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 2001; 28: 400-418.
34. FISHER ER, DIGNAM J, TAN-CHIU E, et al. Pathologic findings from National Surgical Adjuvant Breast Project (NSABP). Eight-year update of protocol B-7. Intraductal carcinoma. Cancer 1999; 86: 429-38.
35. FISHER ER, FISHER B. Relation of a recurrent intraductal carcinoma (Ductal Carcinoma in situ) to the primary tumor. J Natl Cancer Inst 2000; 92: 288-289.
36. JULIEN JP, BIJKER N, FENTIMAN IS, et al. Radiotherapy in breast-conservative treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000; 355: 528-533.
37. BIJKER N, PETERSE JL, DUCHATEAU L, et al. Histological type and marker expression of the primary tumor compared with its local recurrence after breast conserving therapy for ductal carcinoma in situ. Br J Cancer 2001; 84: 539-544.
38. BIJKER N, RUTGERS EJ, PETERSE JL, et al. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast conserving treatment for DCIS. Eur J Surg Oncol 2001; 27: 135-140.
39. FENTIMAN IS, BIJKER N. An update on European organization for research and treatment of cancer trial 10853 for ductal carcinoma in situ of the breast. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 447-452.
40. BIJIKER N, PETERSE JL, FENTIMAN IS, et al. Effect of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS. British J Cancer 2002; 87: 615-620.
41. RECHT A. Randomized trial overview. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 414-419.
42. RECHT A. Salvage of local-regional failure. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 539-544.
43. GAGE I, RECHT A, GELMAN R, et al. Long-term outcome following breast conserving surgery and raditation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 245-251.
44. SOLIN LJ, FOURQUET A, VICINI F, HAFFTY B, TAYLOR M, MC CORMICK B. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer 2001; 91: 1090-1097.
45. BOYAGES J, DELANEY G, TAYLOR R. Predictors of local recurrence after treatment of Ductal Carcinoma In Situ. A meta-analysis. Cancer 1999; 85: 616-628.
46. SILVERSTEIN MJ, LAGIOS MD, GROSHEN S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 1999; 340: 1455-61.
47. FISHER B, DIGNAM J, WOLMARK N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 2000; 353: 1993-2000.
48. CHAN KC, KNOX FW, SINHA G, et al. Extent of excision margin width required in breast conserving surgery for Ductal Carcinoma in situ. Cancer 2001; 91: 9-16.
49. FOWBLE B. Overview of conservative surgery and radiation therapy ductal carcinoma in situ. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 287-302.
50. VICINI FA RECHT A. Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast: a critical review of the literature. J Clin Oncol 2002; 20: 2736-44.
51. ELSTON CW, SLOANE JP, AMENDOEIRA I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. Eur J Cancer 2000; 36: 1769-1772.
52. HOLLAND R, PETERSE JL, MILLIS RR, et al. Ductal Carcinoma In Situ: A proposal for a New Classification. Sem Diag Pathol 1994; 11: 167-180.
53. TABAR L, GAD A, PARSON WC, NEELAND DB. Mammographic Appearances of in situ carcinomas. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 87-104.
54. RUBIN E. Ductal carcinoma in situ: a radiological perspective. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 105-117.
55. HOLLAND R, FAVERLY D. The local distribution of ductal carcinoma in situ of the Breast: whole-organ studies. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 240-248.
56. POLLER DN, SILVERSTEIN MJ. The Van Nuys Ductal Carcinoma in Situ classification: an update. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 222-233.
57. YIANGOU C, JEFFREY J. Problems with the use of the Van Nuys prognostic index. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 474-481.
58. SILVERSTEIN MJ. The University of Southern California/Van Nuys Prognostic Index. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 459-473.
59. ALLRED DC. Biologic characteristics of ductal carcinoma in situ. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 37-48.
60. SILVERSTEIN MJ, WISMAN JR. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 545-553.
61. RUTGERS EJT, RECHT A, BIJKER N. The European organization for researche and treatment of cancer ductal carcinoma in situ consensus meetings. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 587-593.
62. SILVERSTEIN MJ. The University of Southern California/Van Nuys prognostic index. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 459-473.
63. HANSEN NM, GIULIANO AE. Axillary dissection for ductal carcinoma in situ. In: Ductal Carcinoma in situ of the breast 2d Edition; Silverstein MJ, Recht A, Lagios M eds Lippincott William and Wilkins, Philadelphia 2002 pp 554-564.
64. MAC MASTER KM, CHAO C, WOMG SL, et al. Sentinel lymph node biopsy in patients with Ductal Carcinoma in Situ. A proposal. Cancer 2002; 95:15-20.
65. DE MASCAREL I, MAC GROGAN G, MATHOULIN-PELISSIER S, et al. Breast Ductal Carcinoma in Situ with microinvasion. A definition supported by a long-term study of 1248 serially sectioned ductal carcinoma. Cancer 2002; 94: 2131-2142.
66. RUTGERS EJ FOR THE EUSOMA CONSENSUS GROUP. Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001; 37: 447-453.